Evolusion Study Using the Zyga SImmetry Sacroiliac Joint Fusion System

October 8, 2020 updated by: Surgalign Spine Technologies
Sacroiliac joint pain reduction and radiographic evidence of SIJ fusion will be collected to evaluate clinical performance of the SImmetry Sacroiliac Joint Fusion System.

Study Overview

Status

Unknown

Intervention / Treatment

Detailed Description

This is a prospective, non-randomized post market study designed to evaluate fusion and pain reduction following the use of the SImmetry System. This study will be conducted at up to 40 sites and 250 total subjects will be enrolled and followed through 24 months. Data will be collected pre-operatively, implant, and at specified follow-up time points through 24 months.

Study Type

Observational

Enrollment (Actual)

250

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Arizona
      • Phoenix, Arizona, United States, 85023
        • The Core Institute
    • California
      • Newport Beach, California, United States, 92660
        • BASIC Spine
      • Oakland, California, United States, 94611
        • Kaiser Permanente
    • Colorado
      • Lone Tree, Colorado, United States, 80124
        • Rocky Mountain Spine Clinic
    • Florida
      • Daytona Beach, Florida, United States, 32117
        • Orthopaedic Clinic of Daytona Beach
      • Orlando, Florida, United States, 32801
        • Central Florida Neurosurgery Institute
      • Saint Augustine, Florida, United States, 32086
        • Flagler Hospital
    • Georgia
      • Gainesville, Georgia, United States, 30506
        • Gainesville Physical Therapy
    • Indiana
      • Crown Point, Indiana, United States, 46307
        • DK Orthopaedics
    • Kansas
      • El Dorado, Kansas, United States, 67042
        • SBA Medical Center
    • Michigan
      • Kalamazoo, Michigan, United States, 49008
        • Western Michigan University Homer Stryker Md School of Medicine
    • Minnesota
      • Alexandria, Minnesota, United States, 56308
        • Tristate Brain and Spine Institute
      • Duluth, Minnesota, United States, 55805
        • Essentia Health
    • Missouri
      • Cape Girardeau, Missouri, United States, 63701
        • Regional Brain and Spine
    • Oregon
      • Portland, Oregon, United States, 97229
        • Portland Pain and Spine
    • South Carolina
      • Charleston, South Carolina, United States, 29425
        • Medical University of South Carolina
    • South Dakota
      • Rapid City, South Dakota, United States, 57702
        • Black Hills Orthopedic & Spine Center
    • Texas
      • Tyler, Texas, United States, 75701
        • Azalea Orthopedics
    • Utah
      • Salt Lake City, Utah, United States, 84108
        • University of Utah
    • Washington
      • Bellevue, Washington, United States, 98004
        • Bellevue Bone and Joint Physicians
      • Bellingham, Washington, United States, 98225
        • Fourth Corner Neurological Associates
      • Spokane, Washington, United States, 99208
        • Northwest Orthopaedic Specialists

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients will be recruited from the Investigator's standard patient population diagnosed with SIJ pain and representing candidates for SIJ fusion.

Description

Key Inclusion Criteria:

  • At least three positive provocative tests for SIJ pain
  • Non-operative management of SIJ pain for ≥ 6 months prior to surgery
  • At least one positive diagnostic SIJ injection resulting in a ≥ 50% decrease in pain
  • VAS back pain score of ≥ 60 mm
  • The subject is at least 18 years of age

Key Exclusion Criteria:

  • Trauma causing fracture of the sacrum or iliac bones or has had spinal trauma leading to a neurological deficit, or pelvic soft tissue or bony tumors
  • Pregnant or is planning on becoming pregnant in the next two years
  • Chemical dependency abuse problems as evidenced by a history of abusing drugs which is documented in their past medical history or is elicited from an interview.
  • Receiving or seeking worker's compensation, disability remuneration, and/or involved in litigation related to low back or SIJ pain
  • History of significant emotional or psychosocial disturbance

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
SImmetry Implant
Subjects who are indicated for the SImmetry device and meet the inclusion/exclusion criteria will receive a SImmetry implant.

The SImmetry device is commercially available. The implanted devices consist of a range of threaded, self-tapping, cannulated implants designed to transfix the sacrum and ilium, providing stability for intra-articular fusion.

The SImmetry Surgical Instruments include standard manual surgical instruments used to access and prepare the sacroiliac joint space for intra-articular fusion.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
SI Joint Fusion
Time Frame: 12 months
Fusion of the SI joint at 12 and 24 months, defined as presence of a continuous segment of solid bridging bone that extends from the sacrum to the ilium. This will be assessed by an independent core laboratory
12 months
SI Joint Pain Reduction
Time Frame: 6 Months
SI joint pain reduction evaluated by use of Visual Analogue Scale (VAS) for back pain for comparison of baseline to 6 months.
6 Months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
SI Joint Pain Reduction
Time Frame: 12 months
SI joint pain reduction evaluated by use of Visual Analogue Scale (VAS) for back pain for comparison of baseline to all follow-up visits.
12 months
Disability
Time Frame: 6 months
Functional ability as determined by the Oswestry Disability Index
6 months
Quality of Life
Time Frame: 6 months
Quality of life as determined by EQ-5D
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 6, 2015

Primary Completion (Actual)

August 1, 2019

Study Completion (Anticipated)

November 1, 2020

Study Registration Dates

First Submitted

February 26, 2014

First Submitted That Met QC Criteria

February 26, 2014

First Posted (Estimate)

February 28, 2014

Study Record Updates

Last Update Posted (Actual)

October 12, 2020

Last Update Submitted That Met QC Criteria

October 8, 2020

Last Verified

October 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CLP 007-002

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sacroiliac Joint Dysfunction

Clinical Trials on SImmetry

3
Subscribe